Psychopathology in Substance Abusers: Diagnosis and Treatment

References

• Rounsaville B. J., Weissman M. M., Rosenberger P. H., et al. Diagnosis and symptoms of depression in opiate addicts: Course and relationship to treatment outcome. Arch. Gen. Psychiatry 1982; 39: 151–156
   PubMed Web of Science ®Google Scholar
• Kleber H. D., Gold M. S. Use of psychotropic drugs in the treatment of methadone maintained narcotic addicts. Ann. N. Y. Acad. Sci 1978; 331: 81–98
   Google Scholar
• Rounsaville B. J., Weissman M. M., Kleber H., et al. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch. Gen. Psychiatry 1982; 39: 161–166
   PubMed Web of Science ®Google Scholar
• Mirin S. M., Weiss R. D., Sollogub A., Michael J. Affective illness in substance abusers. Substance Abuse and Psychopathology. American Psychiatric Press, Washington, D.C. 1984; 58–77
   Google Scholar
• Weiss R. D., Mirin S. M. Treatment of chronic cocaine abuse and attention deficit disorder, residual type with magnesium pemoline. J. Drug Alcohol Dependence 1985; 15: 69–72
   PubMed Web of Science ®Google Scholar
• Khantzian E. J. An extreme case of cocaine dependence and marked improvement with methylphenidate treatment. Am. J. Psychiatry 1983; 140: 784–785
   PubMed Web of Science ®Google Scholar
• Quitkin F. M., Rifkin A., Kaplan J., et al. Phobic anxiety syndrome complicated by drug dependence and addiction. Arch. Gen. Psychiatry 1972; 27: 159–162
   PubMed Web of Science ®Google Scholar
• Khantzian E. J., Treece C. DSM‐III psychiatric diagnosis of narcotic addicts: Recent findings. Arch. Gen. Psychiatry 1985; 42: 1067–1077
   PubMed Web of Science ®Google Scholar
• Spitzer R. I., Endicott J., Robins E. Research diagnostic criteria: Rationale and reliability. Arch. Gen. Psychiatry 1978; 35: 773–782
   PubMed Web of Science ®Google Scholar
• Mirin S. M., Weiss R. D., Sollogub A., Michael J. Psychopathology in the families of drug abusers. Substance Abuse and Psychopathology, S. M. Mirin. American Psychiatric Press, Washington, D.C. 1984; 80–106
   Google Scholar
• Weiss R. D., Mirin S. M., Michael J. L., et al. Psychopathology in chronic cocaine abusers. Am. J. Drug Alcohol Abuse 1986; 12: 17–29
   PubMed Web of Science ®Google Scholar
• Derogatis L., Rickels K., Rock A. The SCL‐90 and the MMPI: A step in the validation of a new self‐report scale. Br. J. Psychiatry 1976; 128: 280–289
   PubMed Web of Science ®Google Scholar
• Beck A. T., Ward C. H., Mendelson M., et al. An inventory for measuring depression. Arch. Gen. Psychiatry 1961; 4: 561–571
   PubMed Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 56–62
   PubMed Web of Science ®Google Scholar
• Diagnostic and Statistical Manual of Mental Disorders3rd ed. American Psychiatric Press, Washington, D.C. 1981
   Google Scholar
• De Leon‐Jones F., Maas J. W., Dekirmenjian H., et al. Urinary catecholamine metabolite during behavioral changes in a patient with manic‐depressive cycles. Science 1973; 179: 300–302
   PubMed Web of Science ®Google Scholar
• Schildkraut J. J., Orsulak P. J., Schatzberg A. F., et al. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depression. Arch. Gen. Psychiatry 1978; 35: 1427–1433
   PubMed Web of Science ®Google Scholar
• Carroll B. J., Curtis G. C., Mendels J. Neuroendocrine regulation in depression. Arch. Gen. Psychiatry 1976; 33: 1051–1058
   PubMed Web of Science ®Google Scholar
• Gudeman J. E., Schatzberg A. F., Samson J. A., et al. Toward a biochemical classification of depressive disorders. VI. Platelet MAO activity and clinical symptoms in depressed patients. Am. J. Psychiatry 1982; 139: 630–633
   PubMed Web of Science ®Google Scholar
• Mendelewicz J., Rainer J. D. Morbidity risk and genetic transmission in manic‐depressive illness. Am. J. Hum. Genet 1974; 26: 692–701
   PubMed Web of Science ®Google Scholar
• Jackson G. W., Richman A. Alcohol use among narcotic addicts. Alcohol Health Res. World 1973; 1(1)25–28
   Google Scholar
• Freed E. X. Drug abuse by alcoholics: A review. Int. J. Addict 1973; 8(3)451–473
   PubMed Web of Science ®Google Scholar
• Goodwin D. W. Is alcoholism hereditary? A review and critique. Arch. Gen. Psychiatry 1971; 25: 545
   PubMed Web of Science ®Google Scholar
• Goodwin D. W., Schulsinger F., Knop J., et al. Alcoholism and depression in adopted‐out daughters of alcoholics. Arch. Gen. Psychiatry 1977; 34: 751–755
   PubMed Web of Science ®Google Scholar
• Schuckit M. A. A study of young men with alcoholic close relatives. Am. J. Psychiatry 1982; 139: 791–794
   PubMed Web of Science ®Google Scholar
• Gershon E. S., et al. A family study of schizoaffective bipolar I, bipolar II, unipolar and normal control probands. Arch. Gen. Psychiatry 1982; 39: 1157–1167
   PubMed Web of Science ®Google Scholar
• Perris C. The genetics of affective disorders. Biological Psychiatry, J. Mendels. Wiley, New York 1974; 385–415
   Google Scholar
• Weissman M. M., Kidd K. K., Prusoff B. S. Variability in rates of affective disorders in relatives of depressed and normal probands. Arch. Gen. Psychiatry 1982; 39: 1397–1403
   PubMed Web of Science ®Google Scholar
• Winokur G. The division of depressive illness into depression spectrum disease and pure depressive disease. Int. Pharmacopsychiatry 1974; 9: 5–13
   PubMedGoogle Scholar
• Pitts F. N., Winokur G. Affective disorder. VII. Alcoholism and affective disorder. J. Psychiatr. Res 1966; 4: 37–50
   Web of Science ®Google Scholar
• Wise R. A. Neural mechanisms of the reinforcing action of cocaine. Cocaine: Pharmacology, Effects, and Treatment of Abuse, J. Grabowski. National Institute on Drug Abuse Research Monograph 50, Rockville, Maryland 1984
   Google Scholar
• Buchsbaum M. S., Coursey R. D., Murphy D. L. The biochemical high‐risk paradigm: Behavioral and familial correlates of low platelet monoamine oxidase activity. Science 1976; 194: 339
   PubMed Web of Science ®Google Scholar
• Schuckit M. A., et al. Platelet monoamine oxidase activity in relatives of alcoholics: Preliminary study with matched control subjects. Arch. Gen. Psychiatry 1982; 39: 137–140
   PubMed Web of Science ®Google Scholar
• Murphy D. L., Weiss R. Reduced monoamine oxidase activity in blood platelets from bipolar depressed patients. Am. J. Psychiatry 1972; 128: 1351–1357
   PubMed Web of Science ®Google Scholar
• Carroll B. J., Feinberg M., Greden J. F., et al. A specific laboratory test for the diagnosis of melancholia: Standardization, validation, and clinical utility. Arch. Gen. Psychiatry 1981; 38: 15–22
   PubMed Web of Science ®Google Scholar
• Dackis C. A., Gurpegi M., Pottash A. L. C., et al. Methadone induced hypoadrenalism. Lancet 1982; 2: 1167
   PubMed Web of Science ®Google Scholar
• Pheterson A., Dackis C. A., Gold M. S., et al. Plasma cortisol levels in opiate addicts before and after detoxification. Proc. Soc. Neurosci. 1983, Abstract 123.11
   Google Scholar
• Mirin S. M., Meyer R. D., McNamee B. Psychopathology and mood during heroin use: Acute vs. chronic effects. Arch. Gen. Psychiatry 1976; 33: 1503–1508
   PubMed Web of Science ®Google Scholar
• Dackis C. A., Gold M. S. Depression in opiate addicts. Substance Abuse and Psychopathology, S. M. Mirin. American Psychiatric Press, Washington, D.C. 1984; 20–40
   Google Scholar
• Dackis C. A., Gold M. S. Opiate addiction and depression: Cause or effect?. Drug Alcohol Depend 1983; 11: 105–109
   PubMed Web of Science ®Google Scholar
• Kleber H. D., Weissman M. M., Rounsaville B. J. Imipramine as treatment for depression in addicts. Arch. Gen. Psychiatry 1983; 40: 649–653
   PubMed Web of Science ®Google Scholar
• Woody G. E., O'Brien C. P., Rickels K. Depression and anxiety in heroin addicts: A placebo controlled study of doxepin in combination with methadone. Am. J. Psychiatry 1975; 132: 447–450
   PubMed Web of Science ®Google Scholar
• Javaid J. I., et al. Cocaine plasma concentration: Relation to psychological and subjective effects in humans. Science 1978; 202: 227–228
   PubMed Web of Science ®Google Scholar
• Fischman M. W., et al. Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch. Gen. Psychiatry 1976; 33: 983–989
   PubMed Web of Science ®Google Scholar
• Sellinger‐Barnett M. M., Mendels J., Frazer A. The effect of psychoactive drugs on beta‐adrenergic receptor binding sites in rat brain. Neuropharmacology 1980; 19: 447–454
   PubMed Web of Science ®Google Scholar
• Post R. M., Kotin J., Goodwin F. R. The effects of cocaine on depressed patients. Am. J. Psychiatry 1974; 131: 511–517
   PubMed Web of Science ®Google Scholar
• Schildkraut J. J., Watson R., Draskoczy P. R., et al. Amphetamine withdrawal depression and MHPG excretion. Lancet 1971; 1: 485–486
   PubMedGoogle Scholar
• Watson R., Hartmann E., Schildkraut J. J. Amphetamine withdrawal: Affective state, sleep patterns, and MHPG excretion. Am. J. Psychiatry 1972; 129(3)39–45
   Web of Science ®Google Scholar
• Schanberg S. M., Schildkraut J. J., Breese G. R., et al. Metabolism of normetanephrine‐H in rat brain: Identification of conjugated 3‐methoxy‐4‐hydroxy‐phenylglycol (MHPG) as a major metabolite. Biochem. Pharmacol 1968; 17: 247–254
   PubMed Web of Science ®Google Scholar
• Gawin F. H., Kleber H. D. Cocaine abuse treatment: Open pilot trial with desipramine and lithium carbonate. Arch. Gen. Psychiatry 1984; 41: 903–909
   PubMed Web of Science ®Google Scholar
• VanKammen D. P., Murphy D. L. Attenuation of the euphoriant and activating effects of d‐ and l‐amphetamine by lithium carbonate treatment. Psychopharmacologia 1975; 44: 215–224
   PubMedGoogle Scholar
• Cronson A. J., Flemenbaum A. Antagonism of cocaine highs by lithium. Am. J. Psychiatry 1978; 135: 856–857
   PubMed Web of Science ®Google Scholar
• Cole J. O., et al. Assessment of the abuse liability of buspirone in recreational sedative users. J. Clin. Psychiatry 1982; 43(12, Sec. 2)69–74
   PubMed Web of Science ®Google Scholar
• Griffith J. D., et al. Investigation of the abuse liability of buspirone in alcoholdependent patients. Am. J. Med 1986; 80(3B)30–35
   PubMed Web of Science ®Google Scholar
• Sheehan D. V. Current views on the treatment of panic and phobic disorders. Drug Ther. Hosp 1982; 74–93
   Google Scholar
• Sheehan D. V., Ballenger J., Jacobson G. The treatment of endogenous anxiety with phobic, hysterical and hypochondriacal symptoms. Arch. Gen. Psychiatry 1980; 37: 51–59
   PubMed Web of Science ®Google Scholar
• Sheehan D. V., Claycomb J. B., Kouretas N. MAO inhibitors: Prescription and patient management. Int. J. Psychiatry Med 1980; 10: 99–121
   PubMed Web of Science ®Google Scholar